FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2423592568> ?p ?o ?g. }

• W2423592568 endingPage "3" @default.
• W2423592568 startingPage "470" @default.
• W2423592568 abstract "To investigate the prognostic factors and to analyze the efficacy of chemotherapy and/or radiotherapy for Barrett's esophageal adenocarcinoma after radical surgical resection.The clinical data of 108 patients with adenocarcinoma Barrett's esophagus picking out from 783 esophageal adenocarcinoma patients surgically treated between June 1978 to June 2001 in the Shandong Provincial Hospital and Shandong Qianfoshan Hospital were analyzed retrospectively. 60Co gamma-irradiation or 6MVX-ray with conventional fraction were used for radiotherapy with a total volume dosage of 55-70 Gy. The chemotherapy was either FAM (iv infusion of 5-Fu 500 mg, d1-d5; ADM 50 mg d1; MMC 12 mg, d1) or CMF regimen (iv infusion of CTX 800 mg d1, d8; MTX 30 mg d1; 5-Fu 500 mg, d1-d5) for 4-6 cycles. The Kaplan-Meier amalysis was used to estimate the survival rate. Log rank test was used for comparison of the survival difference among different groups.In this series, 76 of 92 patients who underwent radical surgical resection received postoperative radiotherapy alone, and 16 received radiotherapy plus chemotherapy. Twelve of the other 16 patients who underwent palliative surgical resection received chemotherapy plus radiotherapy, the remaining 4 patients died of operative complications during surgery. The overall 1-, 3- and 5-year survival rate of this series was 81.5%, 51.9% and 22.2%, respectively. In the radical resection group, it was 15.8% for the patients received radiotherapy alone versus 75.0% for those treated by chemotherapy plus radiotherapy. The 5-year survival rate was 33.3% for the patients without extra-esophageal infiltration and 33.3% for the patients without lymph node metastasis, respectively. However, it was only 9.1% for the patients with extra-esophageal infiltration and 14.3% for those with lymph node metastasis, respectively. For the patients who had palliative surgical resection, though they received chemotherapy plus radiotherapy postoperatively, none of them survived longer than 5-year. Statistically significant difference among these groups was demonstrated by Log rank test (P < 0.05).Chemotherapy plus radiotherapy after radical surgical resection may improve the survival of patients with adenocarcinoma in Barrett's esophagus adenocarcinoma patient. The pathological stage, extra-esophageal infiltration, lymph node metastasis and postoperative chemotherapy plus radiotherapy are important prognostic factors." @default.
• W2423592568 created "2016-06-24" @default.
• W2423592568 creator A5002739001 @default.
• W2423592568 creator A5005076660 @default.
• W2423592568 creator A5015852068 @default.
• W2423592568 creator A5023787059 @default.
• W2423592568 creator A5048982881 @default.
• W2423592568 creator A5069746277 @default.
• W2423592568 creator A5085028455 @default.
• W2423592568 date "2007-06-01" @default.
• W2423592568 modified "2023-09-26" @default.
• W2423592568 title "[Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus]." @default.
• W2423592568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17974287" @default.
• W2423592568 hasPublicationYear "2007" @default.
• W2423592568 type Work @default.
• W2423592568 sameAs 2423592568 @default.
• W2423592568 citedByCount "0" @default.
• W2423592568 crossrefType "journal-article" @default.
• W2423592568 hasAuthorship W2423592568A5002739001 @default.
• W2423592568 hasAuthorship W2423592568A5005076660 @default.
• W2423592568 hasAuthorship W2423592568A5015852068 @default.
• W2423592568 hasAuthorship W2423592568A5023787059 @default.
• W2423592568 hasAuthorship W2423592568A5048982881 @default.
• W2423592568 hasAuthorship W2423592568A5069746277 @default.
• W2423592568 hasAuthorship W2423592568A5085028455 @default.
• W2423592568 hasConcept C121608353 @default.
• W2423592568 hasConcept C126322002 @default.
• W2423592568 hasConcept C141071460 @default.
• W2423592568 hasConcept C2776283816 @default.
• W2423592568 hasConcept C2776694085 @default.
• W2423592568 hasConcept C2777819096 @default.
• W2423592568 hasConcept C2781182431 @default.
• W2423592568 hasConcept C2781413609 @default.
• W2423592568 hasConcept C509974204 @default.
• W2423592568 hasConcept C71924100 @default.
• W2423592568 hasConceptScore W2423592568C121608353 @default.
• W2423592568 hasConceptScore W2423592568C126322002 @default.
• W2423592568 hasConceptScore W2423592568C141071460 @default.
• W2423592568 hasConceptScore W2423592568C2776283816 @default.
• W2423592568 hasConceptScore W2423592568C2776694085 @default.
• W2423592568 hasConceptScore W2423592568C2777819096 @default.
• W2423592568 hasConceptScore W2423592568C2781182431 @default.
• W2423592568 hasConceptScore W2423592568C2781413609 @default.
• W2423592568 hasConceptScore W2423592568C509974204 @default.
• W2423592568 hasConceptScore W2423592568C71924100 @default.
• W2423592568 hasIssue "6" @default.
• W2423592568 hasLocation W24235925681 @default.
• W2423592568 hasOpenAccess W2423592568 @default.
• W2423592568 hasPrimaryLocation W24235925681 @default.
• W2423592568 hasRelatedWork W147559484 @default.
• W2423592568 hasRelatedWork W2048446937 @default.
• W2423592568 hasRelatedWork W2083166340 @default.
• W2423592568 hasRelatedWork W2349534042 @default.
• W2423592568 hasRelatedWork W2352319395 @default.
• W2423592568 hasRelatedWork W2359895640 @default.
• W2423592568 hasRelatedWork W2379328828 @default.
• W2423592568 hasRelatedWork W2386024498 @default.
• W2423592568 hasRelatedWork W2387577256 @default.
• W2423592568 hasRelatedWork W2414824373 @default.
• W2423592568 hasVolume "29" @default.
• W2423592568 isParatext "false" @default.
• W2423592568 isRetracted "false" @default.
• W2423592568 magId "2423592568" @default.
• W2423592568 workType "article" @default.